Agree . Impressive, upbeat, plan cemented, suitors circling but wont get any part of it cheap. He mentioned whole of world and geographical regions so clearly there are a few suitors with different budgets looking at different pieces of the pie.
Some detailed focus and repeat mention of first half of May and presentations to an eye conference…my suspicion is that this will give the world a taste of just how good the RP11 drug is with a fair number (if not all) of patients seeing better in a measurable way. I’d expect a market release just before that conference as the data, if that good, will be price sensitive imo.
Sell in may and go away might not be a correct strategy for PYC.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)